Communiqués Teleflex Incorporated

Actions

TFX

US8793691069

Equipement, fournitures et distribution médicale

Marché Fermé - NYSE 22:00:02 29/09/2026			Varia. 5j.	Varia. 1 janv.
126,32 ^USD	-0,83%		+1,14%	+3,51%

29/09	Teleflex Incorporated annonce la publication de sa dernière étude évaluée par les pairs démontrant une réduction du risque d’infection sanguine associée aux cathéters centraux avec la technologie Arrowg+ard?	CI
29/09	Nyxoah nomme le successeur de son directeur général sortant	MT

Communiqués

29/09	Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology	BU
08/09	Teleflex Appoints Veteran Medical Technology Executive Sean M. Salmon to Teleflex Board of Directors	BU
04/09	Teleflex Features Innovative Dynetic™-35 Balloon-Expandable Cobalt Chromium Stent System at CIRSE 2026	BU
06/08	Teleflex Incorporated : Q2 2026 Teleflex Incorporated Earnings Call Presentation	PU
06/08	Teleflex Incorporated : Q2 (Q2 2026 Teleflex Incorporated Earnings Call Presentation)	PU
06/08	Teleflex: Q2 Earnings Snapshot	AQ
06/08	Teleflex Announces Quarterly Dividend	BU
06/08	Teleflex Reports Second Quarter Financial Results and Full Year 2026 Outlook	BU
04/08	Teleflex Medical OEM Launches as INGENYX to Empower Tomorrow’s MedTech Innovators	AQ
03/08	Teleflex Completes Strategic Divestiture of OEM Business for $1.5 Billion	BU
30/07	Teleflex Announces FDA BLA Approval of EZPLAZ Freeze Dried Plasma	AQ
29/07	Teleflex Announces FDA BLA Approval of EZPLAZ™ Freeze Dried Plasma	BU
23/07	Teleflex Announces Second Quarter 2026 Earnings Conference Call Information	BU
21/07	Teleflex Awarded National Central Venous Access Agreement with Premier, Inc.	BU
07/07	Teleflex Publishes 2025 Global Impact Report	BU
23/06	Teleflex Initiates Enrollment in Global BIOMAG™‑III Pivotal Trial of Freesolve™ Resorbable Magnesium Scaffold	BU
09/06	Four‑Year BIOMAG™-I Study Results Presented at EuroPCR Confirm Long‑Term Safety and Sustained Performance of the Freesolve™ Resorbable Magnesium Scaffold (DREAMS 3G)	BU
01/06	Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering	BU
01/06	Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes Due 2032	BU
21/05	Teleflex Showcases New Clinical Data at Leading Urological Congresses Highlighting Patient Experience Advantages of the UroLift™ System and Long-Term Toxicity Reduction with Barrigel™ Rectal Spacer	BU
18/05	Teleflex Announces Quarterly Dividend	AQ
15/05	Teleflex Announces Quarterly Dividend	BU
07/05	Teleflex Incorporated : Q1 2026 Teleflex Incorporated Earnings Call Presentation	PU
07/05	Teleflex Incorporated : Q1 (Q1 2026 Teleflex Incorporated Earnings Call Presentation)	PU
07/05	Teleflex: Q1 Earnings Snapshot	AQ